Evidence map›Paper›PMID 36212832›Full record

ReviewFrontiers in microbiology2022

Recent Update on Applications of Quaternary Ammonium Silane as an Antibacterial Biomaterial: A Novel Drug Delivery Approach in Dentistry.

Ranjeet Ajit Bapat, Abhishek Parolia, Tanay Chaubal, Ho Jan Yang, Prashant Kesharwani, Khoo Suan Phaik, Seow Liang Lin, Umer Daood

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Current approaches to produce durable biomaterials: Trends in polymeric materials for restorative dentistry applications.Dental materials : official publication of the Academy of Dental Materials · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Ranjeet Ajit BapatRestorative Dentistry Division, School of Dentistry, International Medical University, Kuala Lumpur, Malaysia.
Abhishek ParoliaRestorative Dentistry Division, School of Dentistry, International Medical University, Kuala Lumpur, Malaysia.
Tanay ChaubalRestorative Dentistry Division, School of Dentistry, International Medical University, Kuala Lumpur, Malaysia.
Ho Jan YangRestorative Dentistry Division, School of Dentistry, International Medical University, Kuala Lumpur, Malaysia.
Prashant KesharwaniSchool of Pharmaceutical Education and Research, Jamia Hamdard (Hamdard University), New Delhi, India.
Khoo Suan PhaikDivision of Clinical Oral Health, School of Dentistry, International Medical University, Kuala Lumpur, Malaysia.
Seow Liang LinRestorative Dentistry Division, School of Dentistry, International Medical University, Kuala Lumpur, Malaysia.
Umer DaoodRestorative Dentistry Division, School of Dentistry, International Medical University, Kuala Lumpur, Malaysia.
International Medical University · MYJamia Hamdard · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Quaternary ammonium silane [(QAS), codename - k21] is a novel biomaterial developed by sol-gel process having broad spectrum antimicrobial activities with low cytotoxicity. It has been used in various concentrations with maximum antimicrobial efficacy and biocompatibility. The antimicrobial mechanism is displayed

Indexed as

antibacterialantimicrobialbiomaterialdentistrydrug deliveryirrigantquaternary ammonium silaneSortase-A

Identifiers

PMID36212832
PMCPMC9539660
OpenAlexW4296828503

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.